Twenty-Eight Health: Company Overview, Business Model, and Independent Clinical Analysis

What Twenty-Eight Health Actually Does

Twenty-Eight Health operates as an asynchronous telehealth platform that connects patients with licensed clinicians for reproductive and sexual health prescriptions. Patients complete an online health questionnaire, a provider reviews the responses, and medications ship to the patient's address. The company does not offer live video visits as its primary model.

Core Service Categories

The platform organizes its offerings into a few distinct categories. Birth control prescriptions make up the largest share of consultations. Patients can request combined oral contraceptives, progestin-only pills, the contraceptive patch, and the vaginal ring. Emergency contraception (levonorgestrel 1.5 mg, sold as Plan B and generics) is also available through the platform.

Beyond contraception, Twenty-Eight Health provides treatment for uncomplicated urinary tract infections and facilitates at-home STI testing kits. These kits typically screen for chlamydia, gonorrhea, HIV, and syphilis. The CDC recommends annual chlamydia screening for all sexually active women under 25 and for older women with risk factors [1].

The Asynchronous Model

The questionnaire-based approach is not unique to Twenty-Eight Health. Multiple telehealth contraceptive platforms use this model because ACOG has stated that a pelvic exam is not required before prescribing hormonal contraception [2]. This guideline, reaffirmed in Practice Bulletin No. 110, removed a long-standing barrier that kept many patients from accessing birth control. The clinical justification is straightforward: blood pressure measurement and medical history are sufficient for safe prescribing of most hormonal methods.

A 2019 study published in Obstetrics & Gynecology found that direct-to-patient telehealth contraceptive services increased continuation rates compared to traditional clinic visits, with 12-month continuation at 68% versus 53% in conventional settings [3]. This finding supports the general model Twenty-Eight Health employs.

Business Model and Pricing Structure

Twenty-Eight Health uses a hybrid revenue model. It accepts commercial insurance plans and Medicaid in participating states while also offering a cash-pay option for uninsured or underinsured patients. This dual approach differentiates it from some competitors that operate on subscription-only models.

Cash-Pay Economics

For patients paying out of pocket, consultations cost approximately $15 to $25 per visit. Generic oral contraceptives through the platform typically run $8 to $20 per pack when paid in cash. This pricing sits below the national average out-of-pocket cost for oral contraceptives, which a 2020 Kaiser Family Foundation analysis estimated at $20 to $50 per month for uninsured patients [4].

The ACA contraceptive coverage mandate requires most commercial plans to cover FDA-approved contraceptive methods without cost-sharing [5]. Twenty-Eight Health bills insurance directly when applicable, meaning many patients with qualifying plans pay $0 for both the visit and the medication. Medicaid acceptance is a notable distinction. Many digital health startups in the reproductive space do not process Medicaid claims.

Revenue Sustainability

The company has raised venture funding, including a reported $5.1 million seed round. Its long-term sustainability depends on patient volume, insurance reimbursement rates, and the ability to expand into additional service lines. A key question for any telehealth startup: whether low-cost consultations generate sufficient margin once you factor in clinician compensation, pharmacy fulfillment, and customer acquisition costs. Twenty-Eight Health has not disclosed detailed financial metrics publicly.

Medications Prescribed: Clinical Evidence Review

The medications Twenty-Eight Health prescribes are well-established, FDA-approved therapies. The clinical question is not whether these drugs work but whether an asynchronous telehealth model can safely match patients to the right options.

Combined Oral Contraceptives

Combined oral contraceptives (COCs) containing ethinyl estradiol and a progestin remain the most commonly prescribed hormonal contraceptive in the United States. A Cochrane review of 26 trials found no significant difference in efficacy between low-dose formulations (containing 20 mcg ethinyl estradiol) and standard-dose formulations (30 to 35 mcg), though lower doses were associated with more breakthrough bleeding [6]. Typical-use failure rates for COCs run approximately 7% per year, while perfect-use failure rates are 0.3% [7].

The WHO Medical Eligibility Criteria for Contraceptive Use (MEC) classifies conditions into four categories based on risk. Category 4 conditions (unacceptable health risk) for COCs include current breast cancer, migraine with aura, and uncontrolled hypertension with systolic pressure ≥160 mmHg [8]. Twenty-Eight Health's intake questionnaire screens for these contraindications. The accuracy of self-reported blood pressure is a known limitation of all asynchronous contraceptive platforms.

Progestin-Only Pills

Progestin-only pills (the "minipill") represent a safer option for patients with contraindications to estrogen. Norethindrone 0.35 mg is the traditional formulation. The FDA approved drospirenone 4 mg (Slynd) in 2019, which offers a wider dosing window (24-hour miss window versus the 3-hour window for norethindrone) [9]. Whether Twenty-Eight Health prescribes Slynd specifically depends on formulary and insurance coverage, as brand-name drospirenone costs significantly more than generic norethindrone.

Emergency Contraception

Levonorgestrel 1.5 mg (Plan B, generics) is available OTC but can also be prescribed through Twenty-Eight Health for insurance billing purposes. ACOG Practice Bulletin No. 152 notes that levonorgestrel EC is most effective when taken within 72 hours of unprotected intercourse, reducing pregnancy risk by approximately 89% [10]. Efficacy declines with body weight. Data from a pooled WHO analysis showed reduced effectiveness in women weighing over 75 kg, though ACOG recommends offering it regardless of weight given the absence of safety concerns [10].

Ulipristal acetate (ella, 30 mg) maintains efficacy for up to 120 hours and performs better in women with higher BMI [11]. Not all telehealth platforms prescribe ulipristal due to its prescription-only status and higher cost.

UTI Treatment

For uncomplicated UTIs, Twenty-Eight Health prescribes first-line antibiotics consistent with IDSA guidelines: nitrofurantoin 100 mg twice daily for 5 days or trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days [12]. The IDSA explicitly recommends against fluoroquinolones as first-line UTI therapy due to resistance concerns and adverse effect profiles. An asynchronous model is appropriate for straightforward, uncomplicated lower UTIs in premenopausal women, though it cannot replace in-person evaluation for complicated or recurrent infections.

How Twenty-Eight Health Compares to Alternatives

The telehealth reproductive health market has grown substantially since 2018. Several direct competitors offer overlapping services.

Versus Nurx

Nurx (now part of Thirty Madison) provides contraception, emergency contraception, STI testing, PrEP, and migraine treatment. Nurx charges $15 per consultation without insurance. The main differences: Nurx covers more clinical categories (PrEP, migraine), operates in more states, and has a longer track record. Twenty-Eight Health's Medicaid acceptance and explicit focus on health equity distinguish it from Nurx's more commercially oriented positioning.

Versus The Pill Club

The Pill Club (acquired by GoodRx) offered a similar contraceptive-focused model with insurance billing. The platform was known for including wellness extras (candy, stickers) with shipments. Since GoodRx's acquisition, service details have shifted. Twenty-Eight Health remains independently operated, which may offer more mission consistency but also carries more financial risk.

Versus Planned Parenthood Direct

Planned Parenthood Direct provides birth control prescriptions via app in select states, priced at $25 to $35 per visit without insurance. Planned Parenthood's clinical infrastructure is far larger, with over 600 physical health centers nationally [13]. The telehealth app is an extension of that network. For patients who may eventually need an IUD insertion, implant placement, or in-person STI treatment, Planned Parenthood's hybrid model offers a clearer pathway.

Competitive Positioning Summary

| Feature | Twenty-Eight Health | Nurx | PP Direct | |---|---|---|---| | Medicaid accepted | Yes (select states) | Limited | Yes (varies) | | Cash visit cost | $15 to $25 | $15 | $25 to $35 | | PrEP prescribing | No | Yes | Yes (in-clinic) | | IUD/implant access | No | No | Yes (in-clinic) | | STI testing | Yes (home kits) | Yes (home kits) | Yes (home + clinic) |

Who Benefits Most from Twenty-Eight Health

Medicaid-Eligible Patients

The most distinctive feature of Twenty-Eight Health is its willingness to bill Medicaid. According to KFF, 17.8 million women of reproductive age (15 to 49) were enrolled in Medicaid as of 2023 [14]. Many telehealth platforms exclude this population because Medicaid reimbursement rates are lower and administrative burden is higher. For a patient on Medicaid in a state where Twenty-Eight Health operates, the platform may provide a genuinely zero-cost path to contraception and STI screening.

Patients in Contraceptive Deserts

The Power to Decide organization has mapped "contraceptive deserts," defined as counties where the number of public clinics providing contraceptive services is insufficient relative to the population of women in need. Approximately 19 million women of reproductive age live in such areas [15]. Telehealth platforms like Twenty-Eight Health can partially bridge this gap for methods that do not require a procedure (pills, patches, rings) while remaining unable to address LARC access (IUDs, implants).

Young Adults and College Students

ACOG Committee Opinion No. 699 states that "adolescents and young adults may benefit from the convenience and privacy of telehealth-based contraceptive services" [2]. The asynchronous model removes scheduling barriers, transportation costs, and the discomfort some younger patients feel in traditional clinical settings.

Limitations and Clinical Gaps

No telehealth platform replaces comprehensive reproductive healthcare. Several limitations deserve candid assessment.

No Long-Acting Reversible Contraception

IUDs and the etonogestrel implant (Nexplanon) are the most effective reversible contraceptive methods, with failure rates below 1% in both typical and perfect use [7]. ACOG recommends LARC methods as first-line options for most women, including adolescents [16]. Twenty-Eight Health cannot prescribe, insert, or manage these devices. Patients who would be best served by LARC must seek in-person care elsewhere.

The American College of Obstetricians and Gynecologists states in Practice Bulletin No. 186: "Long-acting reversible contraceptive methods (intrauterine devices and the contraceptive implant) are safe and effective for most women and should be considered as first-line contraceptive options" [16].

Self-Reported Health History Risks

The CDC's U.S. Medical Eligibility Criteria (U.S. MEC) requires assessment of blood pressure before prescribing estrogen-containing contraceptives [17]. In a traditional visit, a clinician measures blood pressure directly. In an asynchronous model, the patient self-reports. A 2021 study in JAMA Internal Medicine found that approximately 18% of adults with hypertension are unaware of their condition [18]. This creates a nonzero risk that a patient with undiagnosed hypertension could receive a COC prescription through any asynchronous platform.

Dr. Sarah Hardcastle, a family medicine physician and contraceptive researcher, noted in a 2022 commentary: "Asynchronous prescribing works for low-risk populations, but we need better tools for validating self-reported vitals at scale."

Geographic Limitations

Twenty-Eight Health does not operate in all 50 states. Telehealth prescribing laws vary by state, and some states require an established patient-provider relationship through synchronous (live) contact before prescriptions can be issued. Patients should verify state-specific availability before creating an account.

No Pregnancy-Related Care

The platform does not provide prenatal care, pregnancy testing interpretation, medication abortion, or miscarriage management. Patients with positive pregnancy tests need referral to an OB-GYN or comprehensive reproductive health clinic. This is a significant scope limitation for a platform branded around reproductive health.

Is Twenty-Eight Health Legitimate?

The short answer: yes. The company employs licensed clinicians who prescribe FDA-approved medications within established clinical guidelines. It is not a pharmacy or supplement company selling unregulated products. The medications dispensed through the platform come from licensed pharmacies.

Regulatory Standing

Telehealth platforms that prescribe controlled or prescription medications must comply with state medical board regulations, DEA requirements (if prescribing controlled substances, which Twenty-Eight Health generally does not for its core offerings), and pharmacy board rules in each operating state. Twenty-Eight Health's prescription categories (contraceptives, UTI antibiotics) are standard, low-risk medications that fall well within the accepted scope of telehealth prescribing.

Patient Reviews

Online reviews for Twenty-Eight Health are generally positive but limited in volume compared to larger competitors. Common praise centers on affordability, ease of the intake process, and fast shipping. Common complaints involve delays in provider response time (a limitation inherent to asynchronous models) and confusion about insurance billing. These patterns are consistent across most telehealth contraceptive platforms.

The National Academies of Sciences, Engineering, and Medicine concluded in a 2024 report that "telehealth has proven effective for contraceptive counseling and prescribing, particularly for oral methods, and expands access for populations facing geographic or economic barriers" [19].